RxSight, Inc. Educational and Product Announcements for AAO 2023
02 Novembre 2023 - 2:00PM
November 2, 2023 – RxSight, Inc., an ophthalmic
medical device company dedicated to providing high-quality
customized vision to patients following cataract surgery, today
announced educational opportunities and product updates at the
American Academy of Ophthalmology (AAO) Annual Meeting on November
3 – 6 in San Francisco. These include three scientific poster
presentations (PO005, PO457, PO050) and 15 booth presentations
(booth #229). At these events, leading U.S.-based ophthalmologists
are slated to discuss diverse topics, including maximizing clinical
results using the Light Adjustable Lens™ (LAL®) across a broad
range of patient profiles, integration of the adjustable lens
workflow, and real-life case studies showing the impact of
high-quality, customized LAL vision. For the full program of events
taking place at AAO 2023, click here.
One of these presentations (by Steven Slade, MD, of
Houston-based Slade & Baker Vision on November 4 at 10:30 a.m.)
will report clinical results using the LAL+, a new addition to the
LAL family that will become available in the first quarter of 2024.
The LAL+ has a built-in optical feature that is designed to further
extend the depth of focus before light treatments, while preserving
the high-quality vision of the LAL already familiar to customers
and patients.
RxSight’s reconfigured Light Delivery Device (LDD™) will also be
on display during AAO. While providing the same functionality and
outcomes as the standard LDD, this compact model has a smaller
footprint to address global practice space constraints.
About RxSight, Inc.RxSight, Inc. is an
ophthalmic medical device company dedicated to providing
high-quality customized vision to patients following cataract
surgery. The RxSight® Light Adjustable Lens system, comprised of
the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery
Device (LDD™) and accessories, is the first and only commercially
available intraocular lens (IOL) technology that can be adjusted
after surgery, enabling doctors to customize and deliver
high-quality vision to patients after cataract surgery. Additional
information about RxSight can be found at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:ir@rxsight.com
RxSight (NASDAQ:RXST)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
RxSight (NASDAQ:RXST)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024